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 Finally, the study by Khan  et al. 2 pro-
vides an interesting example of the mul-
tiple dilemmas that scientists face when 
attempting to explain the pathogenesis of 
renal diseases on the basis of isolated  ex 
vivo or  in vitro studies. For instance, the 
lack of glomerular gp120 binding to Gb 3 
should be interpreted with caution 
because these studies do not mimic the 
natural mechanism by which HIV-1 inter-
acts with glomerular endothelial cells. 
Learning how HIV-1 or gp120 may be 
able to pass or interact with glomerular 
endothelial cells to reach podocytes and 
tubular epithelial cells would be an essen-
tial step to improve our understanding of 
HIV-associated nephropathy and HIV-
HUS. As discussed above regarding chil-
dren with Stx-HUS, previous  ex vivo and 
 in vitro studies provide similarly conS ict-
ing results regarding the pathogenesis of 
HIV-HUS. For example, the expression of 
DARC in glomerular endothelial cells is 
upregulated in renal sections harvested 
from children with HIV-HUS. 10 However, 
cultured primary human glomerular 
endothelial cells do not express DARC 
protein. In contrast, cultured primary 
human renal glomerular endothelial cells 
express CXCR4 protein and can fuse with 
cells expressing HIV-gp120 by a CD4-
independent mechanism. 9 , ese @ ndings 
suggest that HIV-1 can interact with 
glomerular endothelial cells via CXCR4, 
although CXCR4 cannot be detected in 
renal glomeruli from children with HIV-
HUS (P.E.R. unpublished observations). 
In a similar manner, going back to the 
pathogenesis of Stx-HUS, renal glomeru-
lar endothelial cells from primates are 
Gb 3 -negative  in situ but express Gb 3 in 
culture and are sensitive to Stx-induced 
cytopathology. 4 Finally, Khan  et al. 2 
showed less VT staining in adult glomer-
uli compared with pediatric glomeruli 
and found that the VT binding to adult 
glomeruli could be  ‘ unmasked ’ by removal 
of the lipid composition of the plasma 
membranes with detergents or choles-
terol-removing drugs. Overall, these @ nd-
ings suggest that the adult glomerular VT 
binding sites might be protected from 
toxin binding by unknown factors that are 
susceptible to detergent extraction, and 
they explain the age-and glomerular-
restricted pathology of Stx-HUS. 
 In summary, Khan  et al. 2 have refocused 
the pathological paradigm of Stx-HUS on 
glomerular endothelial cells and explained 
why young children develop Stx-HUS. 
Their findings may also improve our 
understanding of the pathogenesis of HIV 
nephropathy and HIV-HUS. Hopefully, 
more studies will follow their lead and 
con@ rm or expand these relevant clinical 
observations. 
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 Ablation of  klotho and premature 
aging: is 1,25-dihydroxyvitamin D 
the key middleman? 
 Yuen  Fei Wong 1 and  Qihe  Xu 1 
 The reversal of soft-tissue abnormalities and prolonged lifespan 
observed in  klotho  – / –  mice following genetic inactivation of 
1 a -hydroxylase underscores the pathophysiological role of 
1,25-dihydroxyvitamin D in mediating some of the premature 
aging-like features observed in  klotho  – / –  mice. 
 Kidney International (2009)  75, 1137 – 1139.  doi: 10.1038/ki.2009.55 
 Mutation in the  klotho gene of mice ( kl / kl ) 
was @ rst reported by Kuro-o  et al. in 1997, 
characterized by the mice ’ s distinct features 
similar to those observed in the course of the 
aging process in humans. 1 , e associated 
syndrome observed in  kl / kl mice was 
 recapitulated in  klotho knockout mice 
( klotho  – / –  ) described by Tsujikawa  et al. , and 
the phenotypes were described as premature 
aging-like rather than natural aging. 2 Over-
expression of  klotho in mice, on the other 
hand, resulted in an extension of lifespan. 
More important, the  tissue-speci@ c  in vivo 
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expression of  klotho was downregulated in 
the course of aging. 3 Collectively, these 
reports are in accordance with the notion of 
 klotho being a senescence-related gene. 
 After its discovery, the  klotho gene 
received considerable attention, leading to 
exciting findings on its tissue-specific 
localization and its potential molecular 
mechanisms in governing the aging 
machinery. Klotho protein is expressed as 
(1) a transmembrane form that can fur-
ther undergo proteolytic cleavage, and (2) 
a secreted form generated by alternative 
RNA splicing, which is thereupon trans-
ported out of the cells into the circulation. 3 
, e transmembrane form of Klotho pro-
tein, instead of being present on the cell 
surface, was found to localize in the endo-
plasmic reticulum, endosomes, and Golgi 
apparatus, associating with its binding 
protein,   1-Na   +   / K   +   ATPase. 4 Although 
the exact mechanism remains elusive, it is 
speculated that Klotho, especially the 
secreted form, exerts its e- ect via not only 
autocrine but also paracrine and / or endo-
crine signaling, since  klotho ablation 
results in plethoric aging-like syndrome 
despite its tissue-speci@ c expression. 3 
 One of the hallmarks reported in both 
 kl / kl and  klotho  – / –  mice is the strikingly high 
level of 1,25-dihydroxyvitamin D 
(1,25(OH) 2 D 3 ), the activated form of vita-
min D, and 1  -hydroxylase (1  (OH)ase), 
its rate-limiting synthesizing enzyme, asso-
ciated with mineral ion and hormone 
imbalance. 2,3,5 Hypercalcemia and hyper-
phosphatemia are believed to be repercus-
sions of enhanced intestinal absorption 
and / or renal reabsorption stimulated by 
high 1,25(OH) 2 D 3 activity, whereas the 
lower-than-normal parathyroid hormone 
(PTH) expression and circulation levels are 
most likely due to a negative-feedback signal 
exerted by both high 1,25(OH) 2 D 3 and cal-
cium levels. 2 , e abnormal serum level of 
1,25(OH) 2 D 3 in the advent of defective 
 klotho expression was propounded as the 
main culprit mediating most, if not all, of 
the aging-like peculiarities, especially those 
related to mineral ion homeostasis. 2,5 To 
further dissect the pathological role of 
1,25(OH) 2 D 3 in this context, Ohnishi  et al. 5 
(this issue) generated  klotho  – / –  / 1a(OH)ase  –  / –  
double-knockout mice to abolish 
1  (OH)ase, thus eliminating 1,25(OH) 2 D 3 
in  klotho  – / –  mice. Indeed, this work showed 
that eliminating 1,25(OH) 2 D 3 by genetic 
inactivation of 1  (OH)ase reversed or 
abated typical features routinely observed in 
 klotho  – / –  mice, including calcium and phos-
phate levels and the ensuing ectopic calci@ -
cation, PTH level, multiple organ atrophy, 
and growth retardation. 5 Although  klotho  –
 / –  / 1a(OH)ase  – / –  double-knockout mice did 
not thrive, as was evident by their reduced 
body weight and slight growth retardation 
as compared with related wild-type litter-
mates, 5 the obliteration of the aging-like 
features observed in  klotho  – / –  mice should 
be attributed to 1,25(OH) 2 D 3 wipeout. 
 Given the remarkably similar pheno-
types observed in  klotho  – / –  and  Fgf-23  – / –  
knockout mice, and that both models are 
characterized by noticeably high levels of 
1  (OH)ase and 1,25(OH) 2 D 3 , 2,5,6 it was 
proposed that Klotho and fibroblast 
growth factor-23 (FGF-23), a secreted 
protein playing a central role in phosphate 
homeostasis, share the vitamin D signal-
ing pathway(s). 6,7 , e reversal of aging-
like syndrome reported by Ohnishi  et al. 5 
in  klotho  – / –  / 1a(OH)ase  – / –  mice is found to 
be consistent with, albeit not as thorough 
and extensive as, the result seen with  Fgf-
23  – / –  / 1a(OH)ase  – / –  double-knockout 
mice. 7 Indeed, there is compelling evi-
dence that Klotho acts as a cofactor, con-
verting canonical FGF receptors into 
speci@ c receptors of FGF-23, thus aug-
menting FGF-23 signaling. 8 It was also 
recently reported that, in  Fg f-23  – / –
  / klotho  –  / –  double mutants, Klotho is 
required in FGF-23-mediated phosphate 
and vitamin D homeostasis; 6 this reiterates 
the intimate relationship between Klotho 
and FGF-23. , ese reports are congruent 
with the observations of Ohnishi  et al. , 5 
who report an increase in sodium – phos-
phate cotransporter (NaPi2a) expression 
associated with apparent hyperphos-
phatemia in  klotho  – / –  mice despite elevated 
FGF-23, suggesting a defect in FGF-23-
mediated  phosphaturic action following 
 klotho ablation. 
 , e persistently high level of 1  (OH)ase 
in both  klotho  – / –  and  Fgf-23  – / –  knockout 
mice 2,5,6 suggested that Klotho, either in 
conjunction with FGF-23 or via other sig-
naling pathways, may be one of the central 
inhibitory regulators of 1,25(OH) 2 D 3 syn-
thesis. , e ablation of  1a(OH)ase in  klotho  – / –  
mice, however, reversed the serum level of 
FGF-23, 5 implicating regulation of  Fgf-23 
expression by 1,25(OH) 2 D 3 . 7 Notably, it 
was recently reported that besides jointly 
regulating vitamin D homeostasis, the 
FGF-23 – Klotho signaling also stimulates 
proliferation and prevents vitamin D-
induced apoptosis, via Ras and phosphati-
dylinositol-3-kinase transduction 
pathways. 9 This should, at least in part, 
explain the tissue atrophy observed in 
 klotho or  Fgf-23 knockout mice. Although 
current  in vivo evidence does not support 
Klotho-independent activity of FGF-23, 
the signi@ cantly high level of FGF-23 in 
 klotho  – / –  mice, besides the risk of being 
cytotoxic, 5 might activate an alternative 
non-vitamin D-related pathway(s) yet to be 
identi@ ed, giving rise to certain anomalies. 
 Alongside the diminished FGF-23 level, 
several other biochemical parameters, 
including serum levels of calcium, phos-
phate, and PTH, were reversed in  klotho  – / –  
mice with 1  (OH)ase ablation, 5 raising 
the possibility that the rescue stems from 
reversal of multiplex factors rather than 
from the absence of 1,25(OH) 2 D 3 itself. In 
an earlier study, Tsujikawa  et al. reported 
that the reversal of aging-like features in 
 klotho  – / –  mice was similarly achieved by 
feeding the mice a low-vitamin D diet. 2 
Tissue calci@ cation was completely pre-
vented in  klotho  – / –  mice on either a low-
vitamin D or a low-calcium diet but 
persisted in mice fed a low-phosphate diet, 
and the groups on low-calcium and low-
phosphate diets did not maintain normal 
body weight, in contrast to those on a low-
vitamin D diet. 2 , ese @ ndings implied 
that mineral adjustment in itself might not 
reverse the aging-like peculiarities as e8  -
ciently and e- ectively as limiting of the 
1,25(OH) 2 D 3 level in  klotho  – / –  mice. 
 Besides participating in vitamin D regula-
tion in conjunction with FGF-23, Klotho 
has been found to possess pleiotropic e- ects, 
some of which may participate directly or 
indirectly in systemic calcium – phosphate 
homeostasis. It was reported that the extra-
cellular domain of Klotho closely resembles 
  -glycosidase, which is capable of hydrolyz-
ing and stabilizing the distal tubular epithe-
lial calcium channel transient receptor 
potential vanilloid 5 (TRPV5), thus enhanc-
ing tubular reabsorption of calcium. 10 At the 
subcellular level, Klotho binds to Na   +   / K   +  
ATPase and thus enhances its tra8  cking to 
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the cell surface to carry out its activity in 
response to low extracellular calcium levels. 4 
, e consequent increase in Na   +   gradient 
was found to facilitate the rapid tuning of 
extracellular concentration of calcium in the 
choroid plexus and PTH release from the 
parathyroid gland that subsequently regu-
lates systemic calcium – phosphate balance. 4 
, e disruption of tubular calcium reabsorp-
tion via TRPV5 and the significance of 
Klotho – Na   +   / K   +   ATPase association under 
hypercalcemic conditions following Klotho 
de@ cit, however, have yet to be addressed. 
 Other potential actions of Klotho protein 
that are important for basic physiological 
functions include (1) antagonizing the Wnt 
pathway, thus preventing Wnt-triggered cel-
lular senescence; 3 (2) antagonizing the insu-
lin – insulin-like growth factor signaling 
pathway and therefore improving resistance 
to oxidative stress, leading to increased sur-
vival; 3 (3) upregulating nitric oxide synthesis, 
which contributes to normal endothelial 
function; 3 (4)  downregulating proapoptotic 
protein p53 and thus preventing senescence; 3 
and (5) activating protein kinase A and pro-
tein kinase C, and a- ecting downstream 
targets of these protein kinases therea1 er. 3 
Taken together, perturbation of all these 
mechanistic pathways along with the vita-
min D signaling pathway following  klotho 
ablation might, in concert, contribute to the 
senescence-related features ( Figure 1 ). 
 In a nutshell, excessive activation of 
1,25(OH) 2 D 3 — taking into consideration 
both its calcemic and its non-calcemic regu-
latory actions 11 — may indeed be the pri-
mary factor inciting the senescence-related 
phenotypes that follow  klotho ablation, given 
that effectors and mediators of Klotho, 
including TRPV5, Na   +   / K   +   ATPase, and 
FGF-23, have all been reported to intersect 
with the vitamin D-regulatory system 
 ( Figure 1 ). 4,8 – 10 The current challenge, 
 nevertheless, is to explain how the divergent 
targets and pathways of Klotho reconcile 
with each other. , erefore, although most 
features of the  klotho  – / –  mice were seemingly 
reversed in  klotho  – / –  / 1a(OH)ase  – / –  double-
knockout mice, it is imperative to scrutinize 
whether any defects in  klotho  – / –  mice were 
not rescued by genetic inactivation of 
1  (OH)ase. , is would provide valuable 
insight into the additional aforementioned 
functions of Klotho, whether they represent 
the non-vitamin D-regulatory pathway of 
Klotho, and their relationship to 
1,25(OH) 2 D 3 signaling in the prevention of 
premature aging. Another critical factor that 
deserves attention is the putative existence 
of a Klotho-speci@ c receptor 3 that could 
potentially link together all the pathways 
identi@ ed to date. , e regulation of endog-
enous Klotho expression by various endog-
enous and exogenous factors, as well as 
under certain physiological and pathological 
conditions, 3 may be crucial clues for further 
investigations in order to decipher the intri-
cacy of Klotho ’ s mechanisms. 
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 Figure 1  |  Klotho ’ s activity within and beyond the vitamin D – Ca 2  +   / PO 4 
3 –  circuit. Klotho 
regulates various pathways / effectors (yellow) in an autocrine, paracrine, or endocrine manner. FGF-
23 signaling intersects the vitamin D – Ca 2  +   / PO 4 
3 –  circuit, modulating the downstream Ca 2  +   / PO 4 
3 –  
homeostasis (blue) by negatively regulating 1,25(OH) 2 D 3 synthesis, and adjusting PO 4 
3 –  directly, 
bypassing the vitamin D pathway. Klotho also acts via other transduction pathways that may 
partially overlap with the vitamin D – Ca 2  +   / PO 4 
3 –  circuit through specific mediators (green), including 
parathyroid hormone and transient receptor potential vanilloid 5 (TRPV5). It is plausible that Klotho ’ s 
targets cross-talk with each other or with the vitamin D – Ca 2  +   / PO 4 
3 –  circuit and act synchronically to 
prevent premature senescence and maintain lifespan. PKA, protein kinase A; PKC, protein kinase C. 
